IL106564A - Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them - Google Patents
Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL106564A IL106564A IL10656493A IL10656493A IL106564A IL 106564 A IL106564 A IL 106564A IL 10656493 A IL10656493 A IL 10656493A IL 10656493 A IL10656493 A IL 10656493A IL 106564 A IL106564 A IL 106564A
- Authority
- IL
- Israel
- Prior art keywords
- group
- preparation
- pharmaceutical compositions
- compositions containing
- tetrahydronaphthalene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyridine Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9209713A FR2694557B1 (fr) | 1992-08-05 | 1992-08-05 | Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique. |
Publications (2)
Publication Number | Publication Date |
---|---|
IL106564A0 IL106564A0 (en) | 1993-12-08 |
IL106564A true IL106564A (en) | 1997-07-13 |
Family
ID=9432640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10656493A IL106564A (en) | 1992-08-05 | 1993-08-02 | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
US (1) | US5373023A (no) |
EP (1) | EP0582506B1 (no) |
JP (1) | JPH06172282A (no) |
KR (1) | KR940003920A (no) |
AT (1) | ATE134607T1 (no) |
AU (1) | AU660832B2 (no) |
CA (1) | CA2101915A1 (no) |
DE (1) | DE69301639T2 (no) |
DK (1) | DK0582506T3 (no) |
ES (1) | ES2085738T3 (no) |
FI (1) | FI933468A (no) |
FR (1) | FR2694557B1 (no) |
GR (1) | GR3019362T3 (no) |
HU (1) | HU210312B (no) |
IL (1) | IL106564A (no) |
MX (1) | MX9304709A (no) |
NO (1) | NO303494B1 (no) |
NZ (1) | NZ248324A (no) |
ZA (1) | ZA935659B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW281667B (no) * | 1994-02-03 | 1996-07-21 | Synthelabo | |
WO1999005107A1 (en) * | 1997-07-25 | 1999-02-04 | Smithkline Beecham Corporation | Vitronectin receptor antagonist |
KR102424767B1 (ko) * | 2015-11-26 | 2022-07-25 | 주식회사 소모홀딩스엔테크놀러지 | 착색층을 갖는 렌즈의 제조방법 및 그에 의해 제조되는 렌즈 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1101711A (en) * | 1964-01-23 | 1968-01-31 | Bellon Labor Sa Roger | New amides |
GB8603765D0 (en) * | 1986-02-15 | 1986-03-19 | Beecham Wuelfung Gmbh & Co Kg | Compounds |
FR2618149B1 (fr) * | 1987-07-16 | 1989-09-22 | Synthelabo | Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique |
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
US5066680A (en) * | 1989-02-14 | 1991-11-19 | Fujisawa Pharmaceutical Co., Ltd. | Novel substituted-acetamide compound and a process for the preparation thereof |
FR2691064B3 (fr) * | 1992-05-14 | 1996-01-12 | Beecham Laboratoires | Nouveau medicament pour le traitement de l'arythmie. |
-
1992
- 1992-08-05 FR FR9209713A patent/FR2694557B1/fr not_active Expired - Lifetime
-
1993
- 1993-07-27 DE DE69301639T patent/DE69301639T2/de not_active Expired - Fee Related
- 1993-07-27 ES ES93401944T patent/ES2085738T3/es not_active Expired - Lifetime
- 1993-07-27 AT AT93401944T patent/ATE134607T1/de not_active IP Right Cessation
- 1993-07-27 EP EP93401944A patent/EP0582506B1/fr not_active Expired - Lifetime
- 1993-07-27 DK DK93401944.9T patent/DK0582506T3/da active
- 1993-08-02 IL IL10656493A patent/IL106564A/xx not_active IP Right Cessation
- 1993-08-04 FI FI933468A patent/FI933468A/fi unknown
- 1993-08-04 JP JP5193376A patent/JPH06172282A/ja active Pending
- 1993-08-04 NO NO932779A patent/NO303494B1/no unknown
- 1993-08-04 NZ NZ248324A patent/NZ248324A/en unknown
- 1993-08-04 CA CA002101915A patent/CA2101915A1/en not_active Abandoned
- 1993-08-04 KR KR1019930015123A patent/KR940003920A/ko not_active Application Discontinuation
- 1993-08-04 US US08/101,764 patent/US5373023A/en not_active Expired - Fee Related
- 1993-08-04 HU HU9302260A patent/HU210312B/hu not_active IP Right Cessation
- 1993-08-04 ZA ZA935659A patent/ZA935659B/xx unknown
- 1993-08-04 MX MX9304709A patent/MX9304709A/es not_active IP Right Cessation
- 1993-08-04 AU AU44415/93A patent/AU660832B2/en not_active Ceased
-
1996
- 1996-03-19 GR GR960400762T patent/GR3019362T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IL106564A0 (en) | 1993-12-08 |
HU210312B (en) | 1995-03-28 |
US5373023A (en) | 1994-12-13 |
MX9304709A (es) | 1994-02-28 |
NO932779D0 (no) | 1993-08-04 |
NZ248324A (en) | 1994-12-22 |
HUT64940A (en) | 1994-03-28 |
FI933468A0 (fi) | 1993-08-04 |
FI933468A (fi) | 1994-02-06 |
ES2085738T3 (es) | 1996-06-01 |
AU4441593A (en) | 1994-02-10 |
ZA935659B (en) | 1994-03-07 |
EP0582506A1 (fr) | 1994-02-09 |
DK0582506T3 (da) | 1996-07-15 |
NO303494B1 (no) | 1998-07-20 |
DE69301639T2 (de) | 1996-08-01 |
ATE134607T1 (de) | 1996-03-15 |
DE69301639D1 (de) | 1996-04-04 |
FR2694557B1 (fr) | 1994-09-23 |
JPH06172282A (ja) | 1994-06-21 |
HU9302260D0 (en) | 1993-10-28 |
GR3019362T3 (en) | 1996-06-30 |
CA2101915A1 (en) | 1994-02-06 |
AU660832B2 (en) | 1995-07-06 |
KR940003920A (ko) | 1994-03-14 |
EP0582506B1 (fr) | 1996-02-28 |
FR2694557A1 (fr) | 1994-02-11 |
NO932779L (no) | 1994-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10199003I2 (no) | ||
ATE174899T1 (de) | Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
ES8302002A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
NZ214787A (en) | Arylcyclobutylalkylamines and pharmaceutical compositions | |
ATE101128T1 (de) | Neue guanidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
FI941836A (fi) | 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
IL86131A0 (en) | Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
AU626095B2 (en) | Hydroxyalkane carboxylic acid derivatives, their production and use | |
IL106564A (en) | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
DE69409734D1 (de) | Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
NO932418L (no) | Pyrimidinderivater, fremgangsmaate for deres fremstilling og terapeutiske anvendelse derav | |
ES8201539A1 (es) | Procedimiento de preparacion de nuevas ortoarilideneaminofe-netilaminas y de sus sales de adicion con acidos farmacolo- gicamente compatibles | |
AU3626189A (en) | New derivatives of phenothiazine, their preparation and the compositions which contain them | |
ATE36154T1 (de) | 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ES2068685T3 (es) | Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH | Patent void |